Inner Mongolia Furui Medical Science Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000KG1
CNY
56.91
1.21 (2.17%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Inner Mongolia Furui Medical Science Co., Ltd.

Why is Inner Mongolia Furui Medical Science Co., Ltd. ?

1
Poor long term growth as Net Sales has grown by an annual rate of 12.56% and Operating profit at 21.74% over the last 5 years
2
With ROE of 8.88%, it has a very expensive valuation with a 11.03 Price to Book Value
  • Over the past year, while the stock has generated a return of 72.40%, its profits have fallen by -23.1%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Inner Mongolia Furui Medical Science Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Inner Mongolia Furui Medical Science Co., Ltd.
72.4%
0.10
63.08%
China Shanghai Composite
15.45%
1.03
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
12.56%
EBIT Growth (5y)
21.74%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.39
Sales to Capital Employed (avg)
0.75
Tax Ratio
27.81%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
21.67%
ROE (avg)
9.89%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
124
Industry P/E
Price to Book Value
11.03
EV to EBIT
70.30
EV to EBITDA
51.75
EV to Capital Employed
16.55
EV to Sales
13.81
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
23.55%
ROE (Latest)
8.88%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

12What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 314.79 MM

RAW MATERIAL COST(Y)

Fallen by -6.77% (YoY

CASH AND EQV(HY)

Highest at CNY 1,450.15 MM

NET SALES(Q)

Highest at CNY 387.63 MM

OPERATING PROFIT(Q)

Highest at CNY 109.29 MM

PRE-TAX PROFIT(Q)

Highest at CNY 109.77 MM

NET PROFIT(Q)

Highest at CNY 59.01 MM

EPS(Q)

Highest at CNY 0.23

-8What is not working for the Company
INTEREST(HY)

At CNY 1.61 MM has Grown at 25.87%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.49 times

Here's what is working for Inner Mongolia Furui Medical Science Co., Ltd.

Net Profit
At CNY 59.01 MM has Grown at 121.54%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow
Highest at CNY 314.79 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales
Highest at CNY 387.63 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Operating Profit
Highest at CNY 109.29 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (CNY MM)

Pre-Tax Profit
Highest at CNY 109.77 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Pre-Tax Profit
At CNY 109.77 MM has Grown at 69.12%
Year on Year (YoY)
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 59.01 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.23
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv
Highest at CNY 1,450.15 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -6.77% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Inner Mongolia Furui Medical Science Co., Ltd.

Interest
At CNY 1.61 MM has Grown at 25.87%
over previous Semi-Annual period
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Debtors Turnover Ratio
Lowest at 2.49 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio